Entity usage

Showing below up to 50 results in range #1 to #50.

1. Bayesian quantile regression joint models: Inference and dynamic predictions: Label: en
2. Random survival forests with multivariate longitudinal endogenous covariates: Label: en
3. Ensemble methods for survival function estimation with time-varying covariates: Label: en
4. Marginal structural models with latent class growth analysis of treatment trajectories: Statins for primary prevention among older adults: Label: en
5. Inference on the overlap coefficient: The binormal approach and alternatives: Label: en
6. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery: Label: en
7. Observational data for comparative effectiveness research: An emulation of randomised trials of statins and primary prevention of coronary heart disease: Label: en
8. Using information criteria to select smoothing parameters when analyzing survival data with time-varying coefficient hazard models: Label: en
9. Estimation of the average treatment effect with variable selection and measurement error simultaneously addressed for potential confounders: Label: en
10. CFO: Calibration-free odds design for phase I/II clinical trials: Label: en
11. Nonparametric kernel estimation of the probability of cure in a mixture cure model when the cure status is partially observed: Label: en
12. A review of statistical updating methods for clinical prediction models: Label: en
13. Clinical dose–response for a broad set of biological products: A model-based meta-analysis: Label: en
14. Quantile regression for incomplete longitudinal data with selection by death: Label: en
15. MethodCompare: An R package to assess bias and precision in method comparison studies: Label: en
16. Cox regression analysis with missing covariates via nonparametric multiple imputation: Label: en
17. Causal inference with measurement error in outcomes: Bias analysis and estimation methods: Label: en
18. Conditional copula models for correlated survival endpoints: Individual patient data meta-analysis of randomized controlled trials: Label: en
19. Comparison of the marginal hazard model and the sub-distribution hazard model for competing risks under an assumed copula: Label: en
20. Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model: Label: en
21. A joint frailty-copula model between tumour progression and death for meta-analysis: Label: en
22. A novel model for the X-chromosome inactivation association on survival data: Label: en
23. Treatment selection in a randomized clinical trial via covariate-specific treatment effect curves: Label: en
24. A new approach to categorising continuous variables in prediction models: Proposal and validation: Label: en
25. Estimation of required sample size for external validation of risk models for binary outcomes: Label: en
26. K-sample omnibus non-proportional hazards tests based on right-censored data: Label: en
27. Prediction intervals for random-effects meta-analysis: A confidence distribution approach: Label: en
28. Random forests for high-dimensional longitudinal data: Label: en
29. A Bayesian approach for analyzing partly interval-censored data under the proportional hazards model: Label: en
30. Scalable collaborative targeted learning for high-dimensional data: Label: en
31. Pseudo-observations in survival analysis: Label: en
32. A stratification approach using logit-based models for confounder adjustment in the study of continuous outcomes: Label: en
33. Estimating negative likelihood ratio confidence when test sensitivity is 100%: A bootstrapping approach: Label: en
34. Group sequential monitoring based on the maximum of weighted log-rank statistics with the Fleming–Harrington class of weights in oncology clinical trials: Label: en
35. Inverse probability weighted Cox model in multi-site studies without sharing individual-level data: Label: en
36. Multiple imputation with sequential penalized regression: Label: en
37. Group-based multi-trajectory modeling: Label: en
38. Phase I/II dose-finding design for molecularly targeted agent: Plateau determination using adaptive randomization: Label: en
39. Multiple imputation of discrete and continuous data by fully conditional specification: Label: en
40. Factorial analyses of treatment effects under independent right-censoring: Label: en
41. Inferring median survival differences in general factorial designs via permutation tests: Label: en
42. Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case—Application to the early diagnosis of Alzheimer disease: Label: en
43. Bayesian analysis on meta-analysis of case-control studies accounting for within-study correlation: Label: en
44. Variable selection for mixture and promotion time cure rate models: Label: en
45. Adaptive lasso for the Cox regression with interval censored and possibly left truncated data: Label: en
46. Growth charts of human development: Label: en
47. Gene selection for survival data under dependent censoring: A copula-based approach: Label: en
48. Multiple imputation of covariates by fully conditional specification: Accommodating the substantive model: Label: en
49. The asymptotic distribution of the Net Benefit estimator in presence of right-censoring: Label: en
50. An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring: Label: en